Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1509.6000 19.30 (1.30%)
NSE Oct 27, 2026 15:31 PM
Volume: 95,467
 

logo
Rubicon Research Ltd.
13 Nov 2025
1509.60
1.30%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research Ltd. has an average target of 1915.00 from 1 broker.
More from Rubicon Research Ltd.
Recommended
Market closes flat, weighed down by losses in IT stocks
Trendlyne Marketwatch | 27 Oct 2026, 04:04PM
Primary market awaits Jio Platforms' listing as nine new issues enter the pipeline
| 26 Oct 2026, 05:33PM
Pre Monday: An optimist surveys the market during earnings season
The Baseline | 24 Oct 2026